Daniel Sandoval is a Principal Scientist at Pfizer, focusing on biophysics and lead discovery in oncology small molecule programs. Previously, Daniel conducted extensive research as a Postdoctoral Researcher at the University of California San Diego, investigating SARS-CoV-2 interactions and bacterial influences on COVID-19 outcomes. Daniel earned a Ph.D. in Biomedical Sciences from UC San Diego and a B.S. in Biological Sciences from UC Irvine, where foundational research included the molecular processes of angiogenesis and microbial compositions in health. Daniel's background also includes independent undergraduate research at prestigious institutions such as Harvard University and UC Irvine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices